The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 04, 2025
Filed:
Feb. 25, 2019
Applicant:
Asklepios Biopharmaceutical, Inc., RTP, NC (US);
Inventors:
Anne Braae, Midlothian, GB;
Juan Manuel Iglesias Gonzalez, Midlothian, GB;
Joanna Critchley, Midlothian, GB;
Michael Roberts, Midlothian, GB;
Ross Fraser, Midlothian, GB;
Assignee:
ASKLEPIOS BIOPHARMACEUTICAL, INC., Research Triangle Park, NC (US);
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/6806 (2018.01); C12N 15/10 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6806 (2013.01); C12N 15/1034 (2013.01); C12Q 2521/325 (2013.01); C12Q 2522/101 (2013.01); C12Q 2525/204 (2013.01); C12Q 2527/107 (2013.01); C12Q 2537/159 (2013.01); C12Q 2537/163 (2013.01);
Abstract
The present invention relates to methods of enriching target single-stranded nucleic acids in a mixed population of single-stranded nucleic acids. The method involves protecting the target single-stranded nucleic acids and using a 5' exonuclease to digest the non-target single-stranded nucleic acids. The invention also relates to methods of cloning target single-stranded nucleic acids into vectors, and to associated compositions and kits.